Europe Pharmacogenetic Testing Market - Industry Trends and Forecast to 2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	211 Pages	Data Bridge Market Research	October, 2023	DAABD18360505

Best Price Guarantee
Price	from $3,500
Length	211 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2023
SKU	DAABD18360505

Europe Pharmacogenetic Testing Market - Industry Trends and Forecast to 2032

The Europe pharmacogenetic testing market is expected to reach USD 3,423.04 million by 2030 from USD 1,864.88 million in 2022, growing at a CAGR of 8.1% during the forecast period of 2023 to 2030.

Market Segmentation
Europe Pharmacogenetic Testing Market, By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, and Single Gene Tests), Gene Type (CYP2C19, CYP2D6, CYP2C9 AND VKORC1, CYP1A2, HLA-B*1502, HLA-B*5701, CYP2D, OPRM1, ONCOTYPE DX AND MAMMAPRINT, DRD3, D4D4, SLC6A4, HTR2A/C, TMPT, and Others), Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, and Over-the-Counter Medications), Sample (Blood and Saliva), Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology & Hypersensitivity, Dermatology, Gynecology, Oncology, Neurology, and Others), Application (Clinical Practice, Drug Development, and Drug Regulation), End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Research Centres and Academic Institutes, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, and Direct-to-Customer Services), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and rest of Europe) - Industry Trends and Forecast to 2030

Overview of Global Pharmacogenetic Testing Market Dynamics

Driver
• Rapid technological advancement and miniaturization
Restrain

• Environment and health concerns
Opportunity

• Rising research and development and innovative technologies

Market Players

Some of the major market players operating in the Europe pharmacogenetic testing market are:

• Thermo Fisher Scientific
• Illumina, Inc
• QIAGEN
• Sonic Healthcare
• BGI

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Europe Pharmacogenetic Testing Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Dbmr Market Position Grid; 2.7 Multivariate Modelling; 2.8 Type Lifeline Curve; 2.9 Market End User Coverage Grid; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’sfive Forces; 4.3 Industry Insights And Strategic Analysis
5 Market Overview: 5.1 Drivers; 5.1.1 Increasing Adoption Of Personalized Medicine; 5.1.2 Advancements In Genomic Technologies; 5.1.3 Increasing Chronic And Complex Diseases; 5.1.4 Role Of Pharmacogenetic Testing In Drug Discovery And Development; 5.2 Restraints; 5.2.1 Dependency On The Medical And Genomic Expert For Result Interpretation; 5.2.2 Ethical And Privacy Concerns Associated With Pharmacogenetic Testing; 5.3 Opportunities; 5.3.1 Integration With Electronic Health Records (Ehrs); 5.3.2 Artificial Intelligence (Ai) And Machine Learning Integration In Healthcare; 5.4 Challenges; 5.4.1 Challenges In Clinical Implementation Of Pharmacogenetics; 5.4.2 Complexity Associated With Pharmacogenetic Testing Results
6 Europe Pharmacogenetic Testing Market, By Type: 6.1 Overview; 6.2 Whole Genome Sequencing; 6.2.1 Next Generation Sequencing (Ngs); 6.2.2 Sanger Sequencing; 6.3 Whole Exome Sequencing; 6.3.1 Next Generation Sequencing (Ngs); 6.3.2 Sanger Sequencing; 6.4 Array-based Tests; 6.4.1 Glass Slide Arrays; 6.4.2 In—situ Synthesized Arrays; 6.4.3 Self Assembled Arrays; 6.5 Single Gene Tests; 6.5.1 Next Generation Sequencing (Ngs); 6.5.2 Sanger Sequencing
7 Europe Pharmacogenetic Testing Market, By Gene Type: 7.1 Overview; 7.2 Cyp2c19; 7.3 Cyp2d6; 7.4 Cyp2c9 And Vkorc1; 7.5 Cyp1a2; 7.6 Hla-b*1502; 7.7 Hla-b*5701; 7.8 Cyp2d; 7.9 Oprm1; 7.10 Oncotype Dx* And Mammaprint; 7.11 Drd3; 7.12 D4d4; 7.13 Slc6a4; 7.14 Htr2a/C; 7.15 Tmpt; 7.16 Others
8 Europe Pharmacogenetic Testing Market, By Drug Type: 8.1 Overview; 8.2 Prescription Drugs; 8.3 Nutraceuticals; 8.4 Recreational Drugs; 8.5 Herbal Supplements; 8.6 Vitamins; 8.7 Over-the-counter Medications
9 Europe Pharmacogenetic Testing Market, By Sample: 9.1 Overview; 9.2 Blood; 9.3 Saliva
10 Europe Pharmacogenetic Testing Market, By Therapeutic Area: 10.1 Overview; 10.2 Cardiology; 10.3 Gastroenterology; 10.4 Anesthesiology; 10.5 Genomics; 10.6 Endocrinology; 10.7 Immunology & Hypersensitivity; 10.8 Dermatology; 10.9 Gynecology; 10.10 Oncology; 10.11 Neurology; 10.12 Others
11 Europe Pharmacogenetic Testing Market, By Application: 11.1 Overview; 11.2 Clinical Practice; 11.2.1 Side Effects; 11.2.2 Drug Effectiveness; 11.2.3 Dosage; 11.3 Drug Development; 11.3.1 Drug Effectiveness; 11.3.2 Dosage; 11.3.3 Side Effects; 11.4 Drug Regulation; 11.4.1 Side Effects; 11.4.2 Drug Effectiveness; 11.4.3 Dosage
12 Europe Pharmacogenetic Testing Market, By End User: 12.1 Overview; 12.2 Healthcare Providers; 12.3 Pharmaceutical & Biotechnology Companies; 12.4 Research Centres And Academic Institutes; 12.5 Others
13 Europe Pharmacogenetic Testing Market, By Distribution Channel: 13.1 Overview; 13.2 Hospital Pharmacy; 13.3 Retail Pharmacies; 13.4 Mail-order Pharmacies; 13.5 Direct-to-customer Services
14 Europe Pharmacogenetic Testing Market, By Region: 14.1 Europe
15 Europe Pharmacogenetic Testing Market: Company Landscape: 15.1 Company Share Analysis: Europe
16 Swot Analysis
17 Company Profile: 17.1 Thermo Fisher Scientific Inc.; 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Developments; 17.2 Illumina, Inc.; 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Company Share Analysis; 17.2.4 Product Portfolio; 17.2.5 Recent Development; 17.3 Qiagen; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio; 17.3.5 Recent Development; 17.4 Sonic Healthcare; 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Company Share Analysis; 17.4.4 Product Portfolio; 17.4.5 Recent Development; 17.5 Bgi; 17.5.1 Company Snapshot; 17.5.2 Company Share Analysis; 17.5.3 Product Portfolio; 17.5.4 Recent Development; 17.6 23andme, Inc; 17.6.1 Company Snapshot; 17.6.2 Revenue Analysis; 17.6.3 Product Portfolio; 17.6.4 Recent Development; 17.7 Dynamic Dna Laboratories; 17.7.1 Company Snapshot; 17.7.2 Product Portfolio; 17.7.3 Recent Development; 17.8 Eurofins Scientific (2022); 17.8.1 Company Snapshot; 17.8.2 Revenue Analysis; 17.8.3 Product Portfolio; 17.8.4 Recent Development; 17.9 Genewix (A Subsidiary Of Azenta Life Science); 17.9.1 Company Snapshot; 17.9.2 Product Portfolio; 17.9.3 Recent Development; 17.10 Luminex Corporation (A Subsidiary Of Diasorin); 17.10.1 Company Snapshot; 17.10.2 Product Portfolio; 17.10.3 Recent Development; 17.11 Md Labs; 17.11.1 Company Snapshot; 17.11.2 Product Portfolio; 17.11.3 Recent Development; 17.12 Myriad Genetics, Inc.; 17.12.1 Company Snapshot; 17.12.2 Revenue Analysis; 17.12.3 Product Portfolio; 17.12.4 Recent Developments; 17.13 Oneome; 17.13.1 Company Snapshot; 17.13.2 Product Portfolio; 17.13.3 Recent Development; 17.14 Pacbio; 17.14.1 Company Snapshot; 17.14.2 Revenue Analysis; 17.14.3 Product Portfolio; 17.14.4 Recent Development; 17.15 Perkinelmer Inc.; 17.15.1 Company Snapshot; 17.15.2 Revenue Analysis; 17.15.3 Product Portfolio; 17.15.4 Recent Development; 17.16 Pgxt; 17.16.1 Company Snapshot; 17.16.2 Product Portfolio; 17.16.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 Europe Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 2 Europe Whole Genome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 3 Europe Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 4 Europe Whole Exome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 5 Europe Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 6 Europe Array-based Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 7 Europe Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 8 Europe Single Gene Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 9 Europe Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 10 Europe Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 11 Europe Cyp2c19 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 12 Europe Cyp2d6 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 13 Europe Cyp2c9 And Vkorc1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 14 Europe Cyp1a2 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 15 Europe Hla-b*1502 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 16 Europe Hla-b*5701 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 17 Europe Cyp2d In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 18 Europe Oprm1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 19 Europe Oncotype Dx* And Mammaprint In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 20 Europe Drd3 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 21 Europe D4d4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 22 Europe Slc6a4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 23 Europe Htr2a/C In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 24 Europe Tmpt In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 25 Europe Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 26 Europe Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 27 Europe Prescription Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 28 Europe Nutraceuticals In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 29 Europe Recreational Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 30 Europe Herbal Supplements In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 31 Europe Vitamins In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 32 Europe Over-the-counter Medications In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 33 Europe Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 34 Europe Blood In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 35 Europe Saliva In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 36 Europe Pharmacogenetic Testing Market, By Therpaeutic Area, 2021-2030 (Usd Million); Table 37 Europe Cardiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 38 Europe Gastroenterology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 39 Europe Anesthesiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 40 Europe Genomics In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 41 Europe Endocrinology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 42 Europe Immunology & Hypersensitivity In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 43 Europe Dermatology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 44 Europe Gynecology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 45 Europe Oncology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 46 Europe Neurology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 47 Europe Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 48 Europe Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 49 Europe Clinical Practice In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 50 Europe Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 51 Europe Drug Development In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 52 Europe Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 53 Europe Drug Regulation In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 54 Europe Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 55 Europe Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 56 Europe Healthcare Providers In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 57 Europe Pharmaceutical & Biotechnology Companies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 58 Europe Research Centres And Academic Institutes In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 59 Europe Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 60 Europe Pharmacogenetic Testing Market, By Distribution Channel, 2020-2030 (Usd Million); Table 61 Europe Hospital Pharmacy In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 62 Europe Retail Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 63 Europe Mail-order Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 64 Europe Direct-to-customer Services In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 65 Europe Pharmacogenetic Testing Market, By Country, 2021-2030 (Usd Million); Table 66 Europe Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 67 Europe Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 68 Europe Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 69 Europe Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 70 Europe Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 71 Europe Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 72 Europe Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 73 Europe Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 74 Europe Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 75 Europe Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 76 Europe Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 77 Europe Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 78 Europe Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 79 Europe Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 80 Europe Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 81 Germany Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 82 Germany Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 83 Germany Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 84 Germany Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 85 Germany Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 86 Germany Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 87 Germany Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 88 Germany Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 89 Germany Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 90 Germany Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 91 Germany Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 92 Germany Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 93 Germany Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 94 Germany Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 95 Germany Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 96 France Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 97 France Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 98 France Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 99 France Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 100 France Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 101 France Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 102 France Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 103 France Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 104 France Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 105 France Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 106 France Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 107 France Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 108 France Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 109 France Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 110 France Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 111 U.K. Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 112 U.K. Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 113 U.K. Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 114 U.K. Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 115 U.K. Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 116 U.K. Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 117 U.K. Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 118 U.K. Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 119 U.K. Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 120 U.K. Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 121 U.K. Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 122 U.K. Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 123 U.K. Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 124 U.K. Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 125 U.K. Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 126 Italy Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 127 Italy Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 128 Italy Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 129 Italy Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 130 Italy Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 131 Italy Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 132 Italy Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 133 Italy Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 134 Italy Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 135 Italy Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 136 Italy Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 137 Italy Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 138 Italy Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 139 Italy Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 140 Italy Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 141 Spain Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 142 Spain Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 143 Spain Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 144 Spain Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 145 Spain Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 146 Spain Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 147 Spain Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 148 Spain Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 149 Spain Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
List Of Figures: Figure 1 Europe Pharmacogenetic Testing Market: Segmentation; Figure 2 Europe Pharmacogenetic Testing Market: Data Triangulation; Figure 3 Europe Pharmacogenetic Testing Market: Droc Analysis; Figure 4 Europe Pharmacogenetic Testing Market: Europe Vs Regional Market Analysis; Figure 5 Europe Pharmacogenetic Testing Market: Company Research Analysis; Figure 6 Europe Pharmacogenetic Testing Market: Interview Demographics; Figure 7 Europe Pharmacogenetic Testing Market: Dbmr Market Position Grid; Figure 8 Europe Pharmacogenetic Testing Market: Market End User Coverage Grid; Figure 9 Europe Pharmacogenetic Testing Market: Segmentation; Figure 10 Increasing Adoption Of Personalized Medicine Is Driving The Growth Of The Europe Pharmacogenetic Testing Market In The Forecast Period Of 2023 To 2030; Figure 11 Whole Genome Sequencing Segment Is Expected To Account For The Largest Share Of The Europe Pharmacogenetic Testing Market In 2023 & 2030; Figure 12 Drivers, Restraints, Opportunities, And Challenges Of Europe Pharmacogenetic Testing Market; Figure 13 Europe Pharmacogenetic Testing Market: By Type, 2022; Figure 14 Europe Pharmacogenetic Testing Market: By Type, 2023-2030 (Usd Million); Figure 15 Europe Pharmacogenetic Testing Market: By Type, Cagr (2023-2030); Figure 16 Europe Pharmacogenetic Testing Market: By Type, Lifeline Curve; Figure 17 Europe Pharmacogenetic Testing Market: By Gene Type, 2022; Figure 18 Europe Pharmacogenetic Testing Market: By Gene Type, 2023-2030 (Usd Million); Figure 19 Europe Pharmacogenetic Testing Market: By Gene Type, Cagr (2023-2030); Figure 20 Europe Pharmacogenetic Testing Market: By Gene Type, Lifeline Curve; Figure 21 Europe Pharmacogenetic Testing Market: By Drug Type, 2022; Figure 22 Europe Pharmacogenetic Testing Market: By Drug Type, 2023-2030 (Usd Million); Figure 23 Europe Pharmacogenetic Testing Market: By Drug Type, Cagr (2023-2030); Figure 24 Europe Pharmacogenetic Testing Market: By Drug Type, Lifeline Curve; Figure 25 Europe Pharmacogenetic Testing Market: By Sample, 2022; Figure 26 Europe Pharmacogenetic Testing Market: By Sample, 2023-2030 (Usd Million); Figure 27 Europe Pharmacogenetic Testing Market: By Sample, Cagr (2023-2030); Figure 28 Europe Pharmacogenetic Testing Market: By Sample, Lifeline Curve; Figure 29 Europe Pharmacogenetic Testing Market: By Therapeutic Area, 2022; Figure 30 Europe Pharmacogenetic Testing Market: By Therapeutic Area, 2023-2030 (Usd Million); Figure 31 Europe Pharmacogenetic Testing Market: By Therapeutic Area, Cagr (2023-2030); Figure 32 Europe Pharmacogenetic Testing Market: By Therapeutic Area, Lifeline Curve; Figure 33 Europe Pharmacogenetic Testing Market: By Application, 2022; Figure 34 Europe Pharmacogenetic Testing Market: By Application, 2023-2030 (Usd Million); Figure 35 Europe Pharma